AKIVA DIAMOND to Lung Neoplasms
This is a "connection" page, showing publications AKIVA DIAMOND has written about Lung Neoplasms.
Connection Strength
0.125
-
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study. JAMA Oncol. 2021 Dec 01; 7(12):1856-1861.
Score: 0.096
-
Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80?years or older: A retrospective cohort study. Cancer Lett. 2024 Aug 01; 596:217001.
Score: 0.029